Natural killer cell differentiation driven by Tyro3 receptor tyrosine kinases
about
The Axl/Gas6 pathway is required for optimal cytokine signaling during human natural killer cell developmentPhosphatidylserine receptors: enhancers of enveloped virus entry and infectionThe Role of TAM Family Receptors in Immune Cell Function: Implications for Cancer TherapyThe Receptor Tyrosine Kinase AXL in Cancer ProgressionEpithelial cell-directed efferocytosis in the post-partum mammary gland is necessary for tissue homeostasis and future lactationGAS6 enhances repair following cuprizone-induced demyelination.Immunobiology of the TAM receptors.TAM Receptors Are Not Required for Zika Virus Infection in MiceIncreased hematopoietic cells in the mertk-/- mouse peritoneal cavity: a result of augmented migrationRegulation of phagocytosis by TAM receptors and their ligands.Cross-phosphorylation, signaling and proliferative functions of the Tyro3 and Axl receptors in Rat2 cells.Tyro3 receptor tyrosine kinases in the heterogeneity of apoptotic cell uptake.Axl as a mediator of cellular growth and survivalMolecular mechanisms influencing NK cell development: implications for NK cell malignancies.Paternal MHC expression on mouse trophoblast affects uterine vascularization and fetal growth.TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer.Systemic autoimmunity in TAM triple knockout mice causes inflammatory brain damage and cell death.Inhibition of Mer and Axl receptor tyrosine kinases in astrocytoma cells leads to increased apoptosis and improved chemosensitivity.The aged nonhematopoietic environment impairs natural killer cell maturation and function.TAM receptor signaling in immune homeostasis.Taking aim at Mer and Axl receptor tyrosine kinases as novel therapeutic targets in solid tumors.Gene deregulation and chronic activation in natural killer cells deficient in the transcription factor ETS1AXL is an essential factor and therapeutic target for metastatic ovarian cancerGrowth arrest-specific protein 6 plasma concentrations during septic shock.The TAM receptor Mertk protects against neuroinvasive viral infection by maintaining blood-brain barrier integrityLocalization and signaling of the receptor protein tyrosine kinase Tyro3 in cortical and hippocampal neurons.Bone marrow versus thymic pathways of natural killer cell development.TAM receptors in leukemia: expression, signaling, and therapeutic implications.Analysis of the linker for activation of T cells and the linker for activation of B cells in natural killer cells reveals a novel signaling cassette, dual usage in ITAM signaling, and influence on development of the Ly49 repertoire.TAM receptors and the regulation of erythropoiesis in miceMer tyrosine kinase (MerTK) promotes macrophage survival following exposure to oxidative stress.Axl/Gas6 pathway positively regulates FLT3 activation in human natural killer cell developmentA genomic screen identifies TYRO3 as a MITF regulator in melanoma.TAM receptors are dispensable in the phagocytosis and killing of bacteriaEffect of GAS6 and AXL Gene Polymorphisms on Adiposity, Systemic Inflammation, and Insulin Resistance in Adolescents.NK cell self tolerance, responsiveness and missing self recognition.TAM receptor tyrosine kinases as emerging targets of innate immune checkpoint blockade for cancer therapy.Differential Role of Hematopoietic and Nonhematopoietic Cell Types in the Regulation of NK Cell Tolerance and Responsiveness.Axl signaling induces development of natural killer cells in vitro and in vivo.Plasma concentrations of Gas6 (growth arrest specific protein 6) and its soluble tyrosine kinase receptor sAxl in sepsis and systemic inflammatory response syndromes.
P2860
Q24321283-100692FD-661C-4582-B206-165F4CC1AEBFQ27015034-CA699D8D-6D6F-44F3-BFF1-026C831488CBQ27928010-A4FA77E0-E6BE-4650-BDE1-77F724BDAD17Q28068756-09D3A18A-4FAF-4168-9BB7-1AD42FD1F215Q33782283-71D72957-861B-4C29-8EB9-BD4C41D62F45Q33784396-E45E44E3-28FC-4BE1-B946-B9F28A6BDD86Q33796991-E37FF950-5272-4073-8989-1877074BE88AQ33838054-16DD8ADD-0A5D-47BD-9FA1-152E480A6D9CQ33938014-28736EB0-8244-4226-A366-2DDD704068C7Q34271347-72A5EBF2-8163-43EE-8A4C-BC3C600C352EQ34273700-3BDF89BF-9C33-447B-9E48-D33A34138249Q34314664-7133896F-D69E-4E87-AE6F-CAFB22D97CB9Q34619118-67D4E07C-4D3E-4B07-ABCF-4749B511B860Q34636731-6F82C056-49E5-4C7F-B37C-CAC4DC8C70CDQ34652228-D51B248B-33D1-4694-BD90-E5F5D5F13701Q34794927-C0AA5D20-5145-4A1C-BB10-F51D2D2B6E54Q34804259-1F819204-F360-4FC9-A919-3A3151610177Q35111750-EB16C564-C7A4-4CBA-98A6-D6E9252F4A47Q35192120-F27113E6-24BB-41BE-9AC9-92DD2339A0F6Q35819380-2CFA0C2B-16DC-465E-8DAD-68669513B806Q35927501-7C12C78F-8B7A-42FC-823D-D83A7EA678E7Q36074924-FD64181E-E812-4CDB-8A7C-D5BC57D7E9ADQ36127308-FF07BDC6-7722-4115-95D8-2EFB202356C9Q36296549-B001FC2F-85F1-4ED5-A843-56994B097F2DQ36359800-263AA1FB-6EA1-4BDD-9516-6FEAA8B1FF4FQ36439979-904C5CA3-EBF3-4F18-AA6B-A26A47084138Q36652153-7F69F58F-9DB2-4DE9-800D-0621C2A7A422Q36865209-3A9DE127-CAA6-42B7-BC01-FE8700F2682AQ36915920-BA51E16D-7D70-4BE6-9DA6-A21A01F74870Q37112879-CD503380-8C36-4910-8410-8645D0C2F368Q37247570-F8DC2F38-8859-48D2-B6BC-C82F84514DE0Q37310946-EC6E2E5C-F504-430F-9824-75329BFBAC5DQ37386014-1E4CC851-05DE-4BE3-9935-9FF323CEBBDAQ37387215-35917235-9168-4643-8D65-DE55E36E9ADEQ37627863-277CE6E6-E05A-4870-8773-9B5D0EBD4197Q38196030-DE08DBC3-A054-4E9A-939A-FB9970D0B1C1Q39160959-EF16A9C4-28A6-4FFF-8F95-6A2D2C94716FQ39231578-876F7AFE-7A26-4388-971D-2DD001B65F52Q39465363-C6E60827-78BB-40FD-95A8-C6C0FB58995BQ40350583-2E181407-2993-4380-B73F-DDA45627AC98
P2860
Natural killer cell differentiation driven by Tyro3 receptor tyrosine kinases
description
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2006
@ast
im Juli 2006 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2006/07/01)
@sk
vědecký článek publikovaný v roce 2006
@cs
wetenschappelijk artikel (gepubliceerd op 2006/07/01)
@nl
наукова стаття, опублікована в липні 2006
@uk
مقالة علمية (نشرت في يوليو 2006)
@ar
name
Natural killer cell differentiation driven by Tyro3 receptor tyrosine kinases
@ast
Natural killer cell differentiation driven by Tyro3 receptor tyrosine kinases
@en
Natural killer cell differentiation driven by Tyro3 receptor tyrosine kinases
@nl
type
label
Natural killer cell differentiation driven by Tyro3 receptor tyrosine kinases
@ast
Natural killer cell differentiation driven by Tyro3 receptor tyrosine kinases
@en
Natural killer cell differentiation driven by Tyro3 receptor tyrosine kinases
@nl
prefLabel
Natural killer cell differentiation driven by Tyro3 receptor tyrosine kinases
@ast
Natural killer cell differentiation driven by Tyro3 receptor tyrosine kinases
@en
Natural killer cell differentiation driven by Tyro3 receptor tyrosine kinases
@nl
P2093
P2860
P921
P3181
P356
P1433
P1476
Natural killer cell differentiation driven by Tyro3 receptor tyrosine kinases
@en
P2093
Anouk Caraux
Claude Roth
David H. Raulet
Greg Lemke
James P. Di Santo
Nadine Fernandez
Qingxian Lu
Sylvain Riou
P2860
P2888
P304
P3181
P356
10.1038/NI1353
P407
P577
2006-07-01T00:00:00Z
P5875
P6179
1035941077